AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 267 filers reported holding AVANOS MED INC in Q3 2021. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $40,719,000 | -37.3% | 1,174,483 | -43.6% | 0.18% | -40.8% |
| Q3 2021 | $64,987,000 | -31.5% | 2,082,903 | -20.1% | 0.31% | -31.0% |
| Q2 2021 | $94,818,000 | -25.6% | 2,607,033 | -10.5% | 0.45% | -32.0% |
| Q1 2021 | $127,379,000 | -20.0% | 2,912,188 | -16.1% | 0.66% | -27.5% |
| Q4 2020 | $159,246,000 | +41.8% | 3,470,935 | +2.7% | 0.91% | +19.6% |
| Q3 2020 | $112,308,000 | +13.9% | 3,380,740 | +0.8% | 0.76% | +8.1% |
| Q2 2020 | $98,564,000 | +6.6% | 3,353,655 | -2.4% | 0.71% | -15.1% |
| Q1 2020 | $92,488,000 | -17.7% | 3,434,370 | +3.0% | 0.83% | +1.5% |
| Q4 2019 | $112,366,000 | +16.2% | 3,334,297 | +29.1% | 0.82% | +3.1% |
| Q3 2019 | $96,721,000 | -9.7% | 2,581,982 | +5.1% | 0.80% | -11.5% |
| Q2 2019 | $107,086,000 | +4.5% | 2,455,532 | +2.2% | 0.90% | +0.6% |
| Q1 2019 | $102,517,000 | +9.1% | 2,401,987 | +14.5% | 0.89% | -6.4% |
| Q4 2018 | $93,968,000 | -12.4% | 2,097,972 | +34.0% | 0.96% | +0.4% |
| Q3 2018 | $107,271,000 | – | 1,565,996 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |